Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

DBVT

DBV Technologies ADR

Jan 16 • 04:00PM ET

20.78

+1.98 10.53 %

Healthcare • Biotechnology • France • NASD

Jan 16, 6:15 PMDBV Technologies announces it has received €166.7 million in gross proceeds from the full exercise of ABSA and BS warrants from its March 2025 financing, extending funding to support preparation and potential U.S. launch of VIASKIN Peanut.

Peers: ALNY VRNA RARE EHAB ADMA XOMA ARRY AXSM ANAB ASND

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.24	Insider Own	17.37%	Shs Outstand	40.14M	Perf Week	22.16%
Market Cap	834.11M	Forward P/E	-	EPS next Y	-0.43	Insider Trans	-32.63%	Shs Float	33.17M	Perf Month	15.57%
Enterprise Value	780.27M	PEG	-	EPS next Q	-0.20	Inst Own	33.81%	Short Float	2.69%	Perf Quarter	22.24%
Income	-125.37M	P/S	-	EPS this Y	-57.58%	Inst Trans	57.45%	Short Ratio	2.26	Perf Half Y	107.80%
Sales	0.00M	P/B	10.76	EPS next Y	76.67%	ROA	-123.18%	Short Interest	0.89M	Perf YTD	8.40%
Book/sh	1.93	P/C	11.94	EPS next 5Y	38.85%	ROE	-234.58%	52W High	26.18 -20.64%	Perf Year	327.57%
Cash/sh	1.74	P/FCF	-	EPS past 3/5Y	12.94% 24.08%	ROIC	-210.55%	52W Low	3.80 446.83%	Perf 3Y	34.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.27% 7.62%	Perf 5Y	-45.03%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	1.29%	Oper. Margin	-	ATR (14)	1.56	Perf 10Y	-93.72%
Dividend Ex-Date	-	Quick Ratio	1.80	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	62.08	Recom	1.44
Dividend Gr. 3/5Y	- -	Current Ratio	1.80	EPS Q/Q	23.95%	SMA20	10.50%	Beta	-0.98	Target Price	41.13
Payout	-	Debt/Eq	0.30	Sales Q/Q	-	SMA50	26.19%	Rel Volume	1.68	Prev Close	18.80
Employees	109	LT Debt/Eq	0.13	Earnings	Oct 28 AMC	SMA200	76.02%	Avg Volume	394.27K	Price	20.78
IPO	Oct 22, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	24.41% 218.80%	Trades		Volume	660,421	Change	10.53%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-15-25	Initiated	Cantor Fitzgerald	Overweight	$42
Dec-03-25	Initiated	Guggenheim	Buy	$35
May-29-25	Resumed	Goldman	Sell	$7.25
Jan-04-23	Upgrade	Societe Generale	Hold → Buy
Dec-16-22	Downgrade	Goldman	Neutral → Sell
May-10-22	Downgrade	Goldman	Buy → Neutral	$6 → $1.50
Sep-14-21	Upgrade	Societe Generale	Hold → Buy
Jan-22-21	Downgrade	Societe Generale	Hold → Sell
Nov-02-20	Upgrade	Societe Generale	Sell → Hold
Aug-06-20	Downgrade	Societe Generale	Buy → Sell
Aug-05-20	Reiterated	H.C. Wainwright	Buy	$25 → $14
Mar-17-20	Downgrade	Stifel	Buy → Hold	$18 → $6
Jan-09-20	Upgrade	Stifel	Hold → Buy	$10 → $18
Dec-16-19	Initiated	Citigroup	Buy
Sep-05-19	Resumed	Morgan Stanley	Equal-Weight
Jun-17-19	Initiated	Goldman	Buy
Dec-20-18	Downgrade	Stifel	Buy → Hold
Dec-20-18	Downgrade	Jefferies	Buy → Hold
Dec-20-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-20-18	Downgrade	Barclays	Overweight → Equal Weight

Show Previous Ratings

Jan-16-26 06:11PM	DBV Technologies Announces 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing (GlobeNewswire) +10.53%
Jan-12-26 04:00PM	Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 (GlobeNewswire) +5.41% -5.02%
Jan-07-26 04:00PM	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire) +8.18% -5.50%
Jan-05-26 04:00PM	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 (GlobeNewswire) -10.81%
Dec-21-25 07:31AM	H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result (Insider Monkey)
04:01PM	Loading…
Dec-17-25 04:01PM	DBV Launches, Up As Much As 46%, On A New Approach To Peanut Allergy (Investor's Business Daily) +25.42%
08:42AM	These Stocks Are Moving the Most Today: Tesla, Warner Bros., Lennar, DBV Technologies, Jabil, Nucor, Micron, and More (Barrons.com)
07:27AM	DBV to make new approval bid for VIASKIN Peanut on Phase III trial (Clinical Trials Arena)
Dec-16-25 04:05PM	DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years (GlobeNewswire)
Dec-15-25 09:16AM	Here Are Mondays Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More (24/7 Wall St.)
Dec-03-25 09:15AM	Here Are Wednesdays Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendys and More (24/7 Wall St.)
Dec-02-25 04:00PM	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025 (GlobeNewswire)
Nov-11-25 11:50PM	DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years (GlobeNewswire)
Nov-04-25 04:30PM	DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference (GlobeNewswire)
Nov-03-25 04:30PM	DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer (GlobeNewswire)
04:25PM	Loading…
04:25PM	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025 (GlobeNewswire)
Oct-31-25 09:40AM	Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-30-25 04:30PM	DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors (GlobeNewswire) -7.36%
03:00AM	DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting (GlobeNewswire)
Oct-29-25 06:47PM	DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq (GlobeNewswire)
Oct-28-25 04:25PM	DBV Technologies Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-17-25 09:16AM	Strength Seen in DBV Technologies (DBVT): Can Its 6.8% Jump Turn into More Strength? (Zacks)
Oct-06-25 05:02PM	DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq (GlobeNewswire) +7.15%
Sep-23-25 05:04AM	New Strong Sell Stocks for September 23rd (Zacks)
Sep-18-25 04:30PM	DBV Technologies Announces Resignation of Board Member (GlobeNewswire)
Sep-05-25 04:30PM	DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq (GlobeNewswire)
Sep-03-25 04:30PM	DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-01-25 04:05PM	Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025 (GlobeNewswire) +5.76%
Jul-29-25 04:17PM	DBV Technologies announces filing of 2025 Half-Year Report ? Conditions for accessing or consulting the Report (GlobeNewswire)
04:08PM	DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results (GlobeNewswire)
04:30PM	Loading…
Jul-28-25 04:30PM	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
Jul-24-25 07:40AM	Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last? (Zacks)
Jul-22-25 04:30PM	DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer (GlobeNewswire)
Jul-09-25 07:20AM	DBV Technologies Begins Pivotal Peanut Allergy Study, Aims for 2026 FDA Submission. (Insider Monkey)
Jun-25-25 04:15PM	DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 - 3 Years Old (GlobeNewswire) +6.60%
Jun-23-25 09:40AM	Is CoreCard (CCRD) Stock Outpacing Its Business Services Peers This Year? (Zacks) -8.94%
09:40AM	Are Utilities Stocks Lagging E.ON (EONGY) This Year? (Zacks)
09:40AM	Are Transportation Stocks Lagging Euroseas (ESEA) This Year? (Zacks)
09:40AM	Are Finance Stocks Lagging Royal Bank Of Canada (RY) This Year? (Zacks)
09:40AM	Is Great Lakes Dredge & Dock (GLDD) Outperforming Other Construction Stocks This Year? (Zacks)
09:40AM	Is CommVault Systems (CVLT) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
09:40AM	Is Agnico Eagle Mines (AEM) Stock Outpacing Its Basic Materials Peers This Year? (Zacks)
09:40AM	Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? (Zacks)
09:40AM	Are Industrial Products Stocks Lagging Allegion (ALLE) This Year? (Zacks)
Jun-12-25 04:05PM	DBV Technologies to Participate in Upcoming EAACI Congress 2025 (GlobeNewswire) +11.12% -6.09%
Jun-11-25 04:30PM	DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting (GlobeNewswire)
Jun-04-25 04:32PM	Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025 (GlobeNewswire) +5.04%
Jun-03-25 04:30PM	DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document (GlobeNewswire)
May-21-25 09:40AM	Are Medical Stocks Lagging DBV Technologies (DBVT) This Year? (Zacks)
May-16-25 12:00PM	Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A. (DBVT) is a Great Choice (Zacks)
08:50AM	DBV Technologies (DBVT) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-15-25 04:30PM	Combined General Meeting of June 11, 2025 (GlobeNewswire)
May-06-25 04:30PM	Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025 (GlobeNewswire)
May-05-25 04:30PM	DBV Technologies to Participate in the Citizens JMP Life Sciences Conference (GlobeNewswire)
Apr-30-25 04:00PM	DBV Technologies Reports First Quarter 2025 Financial Results (GlobeNewswire)
08:50AM	Here's Why Momentum in DBV Technologies (DBVT) Should Keep going (Zacks)
06:25AM	Why DBV Technologies S.A. (DBVT) is Surging in 2025 (Insider Monkey)
Apr-14-25 08:50AM	Here's What Could Help DBV Technologies (DBVT) Maintain Its Recent Price Strength (Zacks) +6.42%
Apr-11-25 04:30PM	DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document (GlobeNewswire)
Apr-10-25 07:00AM	3 Biopharmaceutical Stocks Bucking the Sell-Off (MarketBeat)
Mar-27-25 10:30PM	DBV Technologies Announces Financing of up to $306.9 Million ( 284.5 Million) to Advance Viaskin Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved (GlobeNewswire) +58.57%
Mar-24-25 03:09AM	DBV Now Plans BLA Submission For Viaskin Peanut Patch In Children 4 - 7-years-old In H1, 2026 (RTT News) -10.62%
02:30AM	DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin Peanut Patch in 4 7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results... (GlobeNewswire)
Feb-25-25 04:01PM	DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress (GlobeNewswire)
Jan-13-25 04:05PM	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire) +8.85% -14.23%
Jan-08-25 04:05PM	DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study (GlobeNewswire) +10.37% +29.77%
Dec-12-24 09:59AM	DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids (Benzinga) +16.72%
Dec-11-24 04:05PM	DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin Peanut Patch in Toddlers 1 3 Years-Old (GlobeNewswire)
Dec-02-24 04:30PM	Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024 (GlobeNewswire) +7.05%
Nov-11-24 04:30PM	DBV Technologies Announces Plan to Implement ADS Ratio Change (GlobeNewswire) -6.07%
Nov-06-24 04:30PM	DBV Technologies Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-24-24 08:31AM	DBV Technologies price target raised to $7 from $5 at H.C. Wainwright (TipRanks) +23.14%
Oct-22-24 04:45PM	DBV Announces Positive Regulatory Updates for the Viaskin Peanut Patch in the United States and Europe (GlobeNewswire)
Oct-18-24 04:30PM	DBV Technologies to Participate in Upcoming ACAAI 2024 Congress (GlobeNewswire)
Oct-14-24 04:30PM	Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024 (GlobeNewswire)
Sep-23-24 04:30PM	DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial (GlobeNewswire) -6.03%
Sep-04-24 04:30PM	DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -5.63%
Aug-02-24 04:30PM	Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 (GlobeNewswire)
Jul-30-24 08:55PM	DBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
05:30PM	DBV Technologies Announces Filing of 2024 Half-Year Report ? Conditions for Accessing or Consulting the Report (GlobeNewswire)
04:30PM	DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results (GlobeNewswire)
Jul-29-24 01:30AM	DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 (GlobeNewswire)
Jul-08-24 04:30PM	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
Jun-05-24 04:30PM	DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
Jun-04-24 04:30PM	Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024 (GlobeNewswire)
May-31-24 09:51AM	DBV Technologies Announces Plan to Implement ADS Ratio Change (GlobeNewswire)
May-30-24 04:30PM	DBV Technologies to Participate in Upcoming EAACI 2024 Congress (GlobeNewswire)
May-17-24 04:30PM	DBV Technologies Announces Plan to Implement ADS Ratio Change (GlobeNewswire) +7.97%
May-16-24 04:30PM	DBV Technologies Announces Results of its 2024 Combined General Meeting (GlobeNewswire)
May-09-24 04:30PM	DBV Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire) -17.77%
May-07-24 11:53PM	DBVT Stock Earnings: DBV Technologies Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:30PM	DBV Technologies Reports First Quarter 2024 Financial Results and Business Update (GlobeNewswire)
Apr-25-24 04:30PM	Combined General Meeting of May 16, 2024 (GlobeNewswire)
Apr-04-24 04:43PM	Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 (GlobeNewswire) -6.67% +10.00%
Mar-08-24 11:01AM	DBV Technologies S.A. (NASDAQ:DBVT) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:33AM	DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document (GlobeNewswire)
Mar-07-24 10:52PM	DBVT Stock Earnings: DBV Technologies Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:30PM	DBV Technologies Reports Full Year 2023 Financial Results and Business Update (GlobeNewswire)
Mar-04-24 04:30PM	DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 (GlobeNewswire)
Feb-20-24 04:30PM	DBV Technologies to Participate in Upcoming AAAAI 2024 Congress (GlobeNewswire) -7.58%

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stephane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EPIC Bpifrance	Member of 10% owner group	Dec 17 '25	Sale	4.85	2,076,990	10,070,232	8,595,472	Dec 19 04:04 PM
EPIC Bpifrance	Member of 10% owner group	Dec 18 '25	Sale	4.19	1,292,103	5,413,912	7,303,369	Dec 19 04:04 PM
Mohideen Pharis	Chief Medical Officer	Nov 20 '25	Sale	2.88	6,496	18,708	103,153	Nov 25 04:15 PM
Mohideen Pharis	Chief Medical Officer	Nov 21 '25	Sale	2.77	1,624	4,498	101,529	Nov 25 04:15 PM
Mohideen Pharis	Chief Medical Officer	Jul 29 '25	Sale	2.22	464	1,030	109,649	Jul 31 04:15 PM
Mohideen Pharis	Chief Medical Officer	May 22 '25	Sale	1.84	397	730	110,113	May 27 04:10 PM
Mohideen Pharis	Chief Medical Officer	Jan 30 '25	Sale	0.85	600	510	110,510	Jan 31 04:59 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DBVT

DBV Technologies ADR

Upgrade your FINVIZ experience